CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 13,100 shares, a growth of 15.9% from the May 15th total of 11,300 shares. Based on an average daily volume of 29,700 shares, the short-interest ratio is currently 0.4 days.
CSPC Pharmaceutical Group Trading Down 1.2 %
CSPCY traded down C$0.04 during trading on Monday, hitting C$3.38. 3,733 shares of the stock were exchanged, compared to its average volume of 25,571. The firm has a 50 day simple moving average of C$3.29 and a 200 day simple moving average of C$3.25. CSPC Pharmaceutical Group has a 1 year low of C$2.63 and a 1 year high of C$3.71.
CSPC Pharmaceutical Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Monday, June 3rd will be issued a dividend of $0.0573 per share. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date is Friday, May 31st.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- When to Sell a Stock for Profit or Loss
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- 3 Monster Growth Stocks to Buy Now
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.